updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
Published 3 months ago • 147 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
2:48
destiny-breast03: t-dxd is superior to t-dm1 in her2 metastatic breast cancer
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
4:25
destiny-breast03: safety follow-up results
-
2:27
destiny-breast03: practice-changing results from esmo 2021
-
0:48
highlights from esmo: destiny-breast03
-
2:16
sabcs 2022: destiny-breast02 destiny-breast03
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
3:09
destiny-breast02: high levels of efficacy of t-dxd in previously treated her2 breast cancer
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
0:59
comparing and sequencing t-dm1 and t-dxd in her2 breast cancer
-
2:58
updated analysis of destiny-gastric02: t-dxd in her2 gej cancer who progressed with trastuzumab
-
2:15
treatment strategies for her2 metastatic breast cancer
-
7:12
t-dxd demonstrates high levels of efficacy in patients with her2 unresectable and/or mbc previo...
-
2:08
destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
0:48
evaluating the safety of t-dxd with radiotherapy in her2 metastatic breast cancer
-
2:52
5-year correlative analysis of atempt: adjuvant t-dm1 vs paclitaxel trastuzumab for stage i her2 bc
-
12:19
sabcs 2022: updated survival results of the randomized, phase 3 study destiny-breast03 q & a